Anavex Life Sciences Corp (AVXL)

[BAR123]

I have a naive question. In what format is the TLR or TLD put out? Most of the time with any company providing data from a trial they put out a press release with the high level data from what the endpoints are and state if they made them or not. Also providing some level of detail from the trial. P values, comparisons on drug dosages, comparisons to competitive drugs , etc. How and when does the full data set come out from the company? Is that the peer review? Is it what they give to the FDA?

Personally I am expecting new data at the J.P. Morgan conference. Not “full “ data but many slides that give us some of the information mentioned above. Especially comparing blarcamisine to biogen and the 30mg to 50mg. Along with the path to approval. We also might see some of the Alz and PDD OLE data. Just as an FYI it also seems like we are seeing our name mentioned more positively in the press over the last days. By design or coincidentally? I’m thinking by design with upgrades coming by some of the bigger guys after the presentation. Maybe even J.P. Morgan. Thanks in advance for the responses.